APA (7th ed.) Citation

Park, Y., Sohn, M., Lee, S. Y., & Lim, S. (2024). Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients. Korean Diabetes Association.

Chicago Style (17th ed.) Citation

Park, Young-Hwan, Minji Sohn, So Yeon Lee, and Soo Lim. Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients. Korean Diabetes Association, 2024.

MLA (9th ed.) Citation

Park, Young-Hwan, et al. Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients. Korean Diabetes Association, 2024.